|
Ningbo Sanxing Medical Electric Co., Ltd. (601567.SS) Avaliação do DCF |
Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
Design Profissional: Modelos Confiáveis E Padrão Da Indústria
Pré-Construídos Para Uso Rápido E Eficiente
Compatível com MAC/PC, totalmente desbloqueado
Não É Necessária Experiência; Fácil De Seguir
Ningbo Sanxing Medical Electric Co.,Ltd. (601567.SS) Bundle
Descubra o verdadeiro potencial da Ningbo Sanxing Medical Electric Co., Ltd. (601567Ss) com nossa calculadora DCF avançada! Ajuste as principais suposições, explore vários cenários e avalie como diferentes mudanças afetam a avaliação da Ningbo Sanxing Medical Electric Co., Ltd. (601567Ss) - Tudo dentro de um único modelo do Excel.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7,092.7 | 7,022.9 | 9,098.2 | 11,462.5 | 14,600.5 | 17,591.0 | 21,194.0 | 25,535.0 | 30,765.1 | 37,066.5 |
| Revenue Growth, % | 0 | -0.9842 | 29.55 | 25.99 | 27.38 | 20.48 | 20.48 | 20.48 | 20.48 | 20.48 |
| EBITDA | 1,404.1 | 1,034.6 | 1,483.3 | 2,500.8 | 3,170.2 | 3,319.8 | 3,999.8 | 4,819.0 | 5,806.0 | 6,995.2 |
| EBITDA, % | 19.8 | 14.73 | 16.3 | 21.82 | 21.71 | 18.87 | 18.87 | 18.87 | 18.87 | 18.87 |
| Depreciation | 212.1 | 231.4 | 303.7 | 390.5 | 402.6 | 555.4 | 669.2 | 806.3 | 971.4 | 1,170.4 |
| Depreciation, % | 2.99 | 3.29 | 3.34 | 3.41 | 2.76 | 3.16 | 3.16 | 3.16 | 3.16 | 3.16 |
| EBIT | 1,192.0 | 803.2 | 1,179.5 | 2,110.3 | 2,767.6 | 2,764.4 | 3,330.6 | 4,012.7 | 4,834.6 | 5,824.9 |
| EBIT, % | 16.81 | 11.44 | 12.96 | 18.41 | 18.96 | 15.71 | 15.71 | 15.71 | 15.71 | 15.71 |
| Total Cash | 2,602.4 | 3,079.9 | 2,959.9 | 5,506.7 | 5,368.8 | 6,962.2 | 8,388.3 | 10,106.4 | 12,176.4 | 14,670.3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 2,342.5 | 2,472.8 | 3,262.2 | 2,869.4 | 3,900.8 | 5,482.8 | 6,605.8 | 7,958.8 | 9,589.0 | 11,553.0 |
| Account Receivables, % | 33.03 | 35.21 | 35.86 | 25.03 | 26.72 | 31.17 | 31.17 | 31.17 | 31.17 | 31.17 |
| Inventories | 640.1 | 1,150.0 | 1,802.2 | 3,256.6 | 4,077.1 | 3,572.5 | 4,304.3 | 5,185.9 | 6,248.1 | 7,527.8 |
| Inventories, % | 9.02 | 16.38 | 19.81 | 28.41 | 27.92 | 20.31 | 20.31 | 20.31 | 20.31 | 20.31 |
| Accounts Payable | 2,026.3 | 2,372.0 | 2,561.1 | 2,650.4 | 692.8 | 4,164.1 | 5,017.0 | 6,044.6 | 7,282.7 | 8,774.4 |
| Accounts Payable, % | 28.57 | 33.77 | 28.15 | 23.12 | 4.74 | 23.67 | 23.67 | 23.67 | 23.67 | 23.67 |
| Capital Expenditure | -206.4 | -295.2 | -403.9 | -555.9 | -1,044.6 | -828.8 | -998.5 | -1,203.1 | -1,449.5 | -1,746.4 |
| Capital Expenditure, % | -2.91 | -4.2 | -4.44 | -4.85 | -7.15 | -4.71 | -4.71 | -4.71 | -4.71 | -4.71 |
| Tax Rate, % | 15.45 | 15.45 | 15.45 | 15.45 | 15.45 | 15.45 | 15.45 | 15.45 | 15.45 | 15.45 |
| EBITAT | 958.9 | 654.5 | 970.7 | 1,776.0 | 2,339.8 | 2,283.0 | 2,750.6 | 3,314.0 | 3,992.8 | 4,810.6 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 8.3 | 296.1 | -381.9 | 638.2 | -2,111.6 | 4,403.6 | 1,419.4 | 1,710.2 | 2,060.4 | 2,482.5 |
| WACC, % | 5.71 | 5.71 | 5.72 | 5.72 | 5.72 | 5.72 | 5.72 | 5.72 | 5.72 | 5.72 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 10,412.7 | |||||||||
| Long Term Growth Rate, % | 3.50 | |||||||||
| Free cash flow (T + 1) | 2,569 | |||||||||
| Terminal Value | 115,932 | |||||||||
| Present Terminal Value | 87,800 | |||||||||
| Enterprise Value | 98,213 | |||||||||
| Net Debt | -338 | |||||||||
| Equity Value | 98,551 | |||||||||
| Diluted Shares Outstanding, MM | 1,412 | |||||||||
| Equity Value Per Share | 69.79 |
What You Will Receive
- Authentic 601567SS Financial Data: Equipped with Ningbo Sanxing Medical Electric's historical and projected figures for accurate analysis.
- Completely Customizable Template: Easily adjust key metrics such as revenue growth, WACC, and EBITDA percentage.
- Instant Calculations: Watch as Ningbo Sanxing Medical Electric's intrinsic value updates in real-time based on your modifications.
- Professional Valuation Tool: Tailored for investors, analysts, and consultants aiming for precise DCF results.
- User-Friendly Interface: Intuitive layout and straightforward instructions suitable for all levels of expertise.
Core Highlights
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for Ningbo Sanxing Medical Electric Co.,Ltd. (601567SS).
- WACC Calculator: Ready-to-use Weighted Average Cost of Capital sheet with adjustable parameters.
- Customizable Forecast Inputs: Adjust growth rates, capital expenditures, and discount rates as needed.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specific to Ningbo Sanxing Medical Electric Co.,Ltd. (601567SS).
- Visual Dashboard and Charts: Graphical representations of essential valuation metrics for straightforward analysis.
How It Works
- Step 1: Download the pre-built Excel template featuring data for Ningbo Sanxing Medical Electric Co., Ltd. (601567SS).
- Step 2: Review the pre-filled sheets to grasp the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly see recalculated results, including the intrinsic value of Ningbo Sanxing Medical Electric Co., Ltd. (601567SS).
- Step 5: Use the outputs to make well-informed investment decisions or to create detailed reports.
Why Opt for This Calculator?
- All-in-One Solution: Combines DCF, WACC, and financial ratio analyses into a single tool.
- Flexible Inputs: Modify the yellow-highlighted fields to explore different scenarios.
- In-Depth Analysis: Automatically computes the intrinsic value and Net Present Value of Ningbo Sanxing Medical Electric Co., Ltd. (601567SS).
- Preloaded Information: Historical and forecast data provide a solid foundation for analysis.
- High-Quality Standards: Perfect for financial analysts, investors, and business advisors.
Who Can Benefit from This Product?
- Healthcare Investors: Develop comprehensive and accurate valuation models for assessing investment opportunities in medical technology.
- Corporate Finance Departments: Evaluate valuation scenarios to inform strategic decisions within healthcare organizations.
- Consultants and Financial Advisors: Deliver precise valuation insights to clients considering investments in Ningbo Sanxing Medical Electric Co., Ltd. (601567SS).
- Students and Faculty: Utilize real-life data to learn and instruct on financial modeling techniques in the medical sector.
- Medical Technology Enthusiasts: Gain insights into the valuation processes for companies in the healthcare technology space.
Overview of Template Features
- Pre-Filled DCF Model: Ningbo Sanxing Medical Electric Co., Ltd.'s financial data preloaded for immediate analysis.
- WACC Calculator: Comprehensive calculations for the Weighted Average Cost of Capital.
- Financial Ratios: Assess Ningbo Sanxing's profitability, leverage, and operational efficiency.
- Editable Inputs: Modify assumptions including growth rates, margins, and CAPEX to suit your analysis.
- Financial Statements: Access annual and quarterly reports for in-depth evaluation.
- Interactive Dashboard: Effortlessly visualize essential valuation metrics and outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.